📣 VC round data is live. Check it out!

Mani Inc. Valuation Multiples

Discover revenue and EBITDA valuation multiples for Mani Inc. and similar public comparables like Curiox Biosystems, Shanghai Haohai, Arcs Co, Conmed and more.

Mani Inc. Overview

About Mani Inc.

Mani Inc manufactures medical devices and dental instruments. It sells products in four categories: surgical instruments, ophthalmic instruments, suture needles, and dental instruments. Mani's surgical products include instruments such as staplers, vessel knives, and bone saws. Its ophthalmic instruments include a range of knives used during eye surgery and ophthalmic sutures. Mani's suture needles business includes a variety of taper point and cutting eyeless needles, which require suture attachment and sterilization by the customer, as well as stainless-steel eyed needles. The firm's dental instruments include endodontic instruments and accessories, root canal equipment, and finishing and polishing instruments.


Founded

1959

HQ

Japan

Employees

3.7K

Website

mani.co.jp

Financials (LTM)

Revenue: $205M
EBITDA: $75M

EV

$907M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Mani Inc. Financials

Mani Inc. reported last 12-month revenue of $205M and EBITDA of $75M.

In the same LTM period, Mani Inc. generated $138M in gross profit, $75M in EBITDA, and $43M in net income.

Revenue (LTM)


Mani Inc. P&L

In the most recent fiscal year, Mani Inc. reported revenue of $196M and EBITDA of $70M.

Mani Inc. is profitable as of last fiscal year, with gross margin of 62%, EBITDA margin of 36%, and net margin of 17%.

See analyst estimates for Mani Inc.
LTMLast FY202320242025202620272028
Revenue$205M$196M$162M$182M$195M
Gross Profit$138M$121M$102M$115M$128M
Gross Margin67%62%63%63%66%
EBITDA$75M$70M$64M$65M$65M
EBITDA Margin36%36%39%36%34%
EBIT Margin29%27%30%29%28%
Net Profit$43M$34M$38M$36M$35M
Net Margin21%17%23%20%18%

Financial data powered by Morningstar, Inc.

Mani Inc. Stock Performance

Mani Inc. has current market cap of $1B, and enterprise value of $907M.

Market Cap Evolution


Mani Inc.'s stock price is $10.66.

Mani Inc. share price decreased by 3.1% in the last 30 days, and increased by 37.1% in the last year.

Mani Inc. has an EPS (earnings per share) of $0.34.

See more trading valuation data for Mani Inc.
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$907M$1B-3.1%-3.1%12.5%37.1%$0.34

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Mani Inc. Valuation Multiples

Mani Inc. trades at 4.4x EV/Revenue multiple, and 12.2x EV/EBITDA.

See NTM and 2027E valuation multiples for Mani Inc.

EV / Revenue (LTM)


Mani Inc. Financial Valuation Multiples

As of June 3, 2026, Mani Inc. has market cap of $1B and EV of $907M.

Mani Inc. has a P/E ratio of 24.5x.

LTMLast FY202320242025202620272028
EV/Revenue4.4x4.6x5.6x5.0x4.7x
EV/EBITDA12.2x13.0x14.2x14.0x13.9x
EV/EBIT15.2x16.9x19.0x17.4x16.5x
EV/Gross Profit6.6x7.5x8.9x7.9x7.1x
P/E24.5x31.1x27.6x29.2x30.3x
EV/FCF30.6xn/m49.7xn/m62.6x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Mani Inc. Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Mani Inc. Margins & Growth Rates

Mani Inc. grew revenue by 6% and EBITDA by 9% in the last fiscal year.

In the most recent fiscal year, Mani Inc. reported gross margin of 62%, EBITDA margin of 36%, and net margin of 17%.

See estimated margins and future growth rates for Mani Inc.

Mani Inc. Margins

Last FY202420252026202720282029
Gross Margin62%63%66%68%
EBITDA Margin36%36%34%37%
EBIT Margin27%29%28%30%
Net Margin17%20%18%22%
FCF Margin1%1%7%19%

Mani Inc. Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth6%12%7%10%
Gross Profit Growth17%13%11%14%
EBITDA Growth9%1%1%21%
EBIT Growth15%9%5%17%
Net Profit Growth36%(5%)(4%)36%
FCF Growth1699%(93%)1046%181%

Data powered by FactSet, Inc. and Morningstar, Inc.

Mani Inc. Operational KPIs

Mani Inc.'s revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.

Mani Inc.'s Rule of 40 is 47% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Mani Inc.'s Rule of X is 62% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Mani Inc.
LTMLast FY202320242025202620272028
Rule of 4045%47%---
Bessemer Rule of X57%62%---
Revenue per Employee-$0.1M---
Opex per Employee-$0.0M---
R&D Expenses to Revenue8%9%-9%9%
Opex to Revenue-36%33%35%36%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Mani Inc. Competitors

Mani Inc. competitors include Curiox Biosystems, Shanghai Haohai, Arcs Co, Conmed, MedicalSystem Technology, ChemoMetec, Artivion, SEEGENE, Medartis and iRadimed.

Most Mani Inc. public comparables operate across Medical Devices, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Curiox Biosystems303.7x303.7x(67.6x)-
Shanghai Haohai2.0x2.0x10.7x9.6x
Arcs Co0.2x0.2x3.7x3.8x
Conmed1.3x1.3x6.7x6.7x
MedicalSystem Technology21.4x19.2x72.6x83.5x
ChemoMetec12.2x11.9x23.3x21.7x
Artivion2.7x2.6x13.3x12.9x
SEEGENE1.9x1.9x7.4x7.7x

This data is available for Pro users. Sign up to see all Mani Inc. competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Mani Inc.

When was Mani Inc. founded?Mani Inc. was founded in 1959.
Where is Mani Inc. headquartered?Mani Inc. is headquartered in Japan.
How many employees does Mani Inc. have?As of today, Mani Inc. has over 3K employees.
Who is the CEO of Mani Inc.?Mani Inc.'s CEO is Masaya Watanabe.
Is Mani Inc. publicly listed?Yes, Mani Inc. is a public company listed on Tokyo Stock Exchange.
What is the stock symbol of Mani Inc.?Mani Inc. trades under 7730 ticker.
When did Mani Inc. go public?Mani Inc. went public in 2001.
Who are competitors of Mani Inc.?Mani Inc. main competitors include Curiox Biosystems, Shanghai Haohai, Arcs Co, Conmed, MedicalSystem Technology, ChemoMetec, Artivion, SEEGENE, Medartis, iRadimed.
What is the current market cap of Mani Inc.?Mani Inc.'s current market cap is $1B.
What is the current revenue of Mani Inc.?Mani Inc.'s last 12 months revenue is $205M.
What is the current revenue growth of Mani Inc.?Mani Inc. revenue growth (NTM/LTM) is 8%.
What is the current EV/Revenue multiple of Mani Inc.?Current revenue multiple of Mani Inc. is 4.4x.
What is the current EBITDA of Mani Inc.?Mani Inc.'s last 12 months EBITDA is $75M.
What is Mani Inc.'s EBITDA margin?Mani Inc.'s last 12 months EBITDA margin is 36%.
What is the current EV/EBITDA multiple of Mani Inc.?Current EBITDA multiple of Mani Inc. is 12.2x.
What is the current FCF of Mani Inc.?Mani Inc.'s last 12 months FCF is $30M.
What is Mani Inc.'s FCF margin?Mani Inc.'s last 12 months FCF margin is 14%.
What is the current EV/FCF multiple of Mani Inc.?Current FCF multiple of Mani Inc. is 30.6x.
How many companies Mani Inc. has acquired to date?Mani Inc. hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Mani Inc. has invested to date?Mani Inc. hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Mani Inc.

Lists including Mani Inc.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial